{"name":"Huabo Biopharm Co., Ltd.","slug":"huabo-biopharm-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HB0017 Q4W","genericName":"HB0017 Q4W","slug":"hb0017-q4w","indication":"Treatment of moderate to severe rheumatoid arthritis","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"HB0017 Q8W","genericName":"HB0017 Q8W","slug":"hb0017-q8w","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"HB0025","genericName":"HB0025","slug":"hb0025","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"HB0017 Q4W","genericName":"HB0017 Q4W","slug":"hb0017-q4w","phase":"phase_3","mechanism":"HB0017 Q4W is a monoclonal antibody targeting a specific protein to modulate the immune system.","indications":["Treatment of moderate to severe rheumatoid arthritis"],"catalyst":""},{"name":"HB0017 Q8W","genericName":"HB0017 Q8W","slug":"hb0017-q8w","phase":"phase_3","mechanism":"HB0017 Q8W is a monoclonal antibody targeting the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"HB0025","genericName":"HB0025","slug":"hb0025","phase":"phase_3","mechanism":"HB0025 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPbGQ2ZjVkM3RPV0RkbTdVbnhHMnlVMlpoaDk2dVlBZVJ6ZFhCWWFURWJvbHVfV1A4cjRkR3UwNXV4SGZ5Yl9nRV9XZ0hYVW1sM3dqZHlVNGV3S1hHRXZlZTV3UVZlTnlHbEZ3RjItdnYyRWZLNkVkM0RzTURyRktoemJnbUxyNW1zamtySmFhZXVlTER4UDRoRjI0Yno?oc=5","date":"2026-03-18","type":"trial","source":"openPR.com","summary":"Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+ - openPR.com","headline":"Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNRjQ3VUh4R0ZtbmdYQmJiNDFOSm03MXFtYXl3dG9OWV9sdlNvRlEyWXBhUmxzN3VGWktRWktnQ05tUm1RSDNBSk1mZGgzTlJSMk1kMWxYelNXUE1VdDg2WGlieE8zYzE5Sl9KWHJXYlo5N2dtTUJaWDlrMkdOeFB3ckEzeEN5V2hZNlFvTktxMDNBamFjRFdKZWtramdlR0t0T2FCQmc2OGJiSGJhZGpDdlBkNUVFcWJ2eDV4WksyOGEtQVVSbm1HWEt5WXZ1V29YTDlQTjB4d3JaUnZMOEV3ajg0U1FKTGNHdVc2aFNHWldFYXF0NTlQeWlsajJqWHJPX3NOQU8zVUdEazRUaDFBdlRGLVdYclpZSGdldWY4aWR6dw?oc=5","date":"2025-11-06","type":"trial","source":"PR Newswire","summary":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - PR Newswire","headline":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immuno","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOaW4zU0poVnpIb2JTODhiOEZ0a1IxRGtKYlhnMDhQelF3eU92RVRDdGdockRkYXQ5MDJLeHAzZzdEVEdhajB5dlg3UWxBanlxTkUyU2JLUWZ2TnBrNkkyMENsOWJKeE1MeHd0YVhfM2lqTTM2dERYV01SdHp0aWZWUlV5MFdlOEpDOVE3aUVTcTdNQQ?oc=5","date":"2025-07-15","type":"trial","source":"Yahoo Finance","summary":"Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - Yahoo Finance","headline":"Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQbmNQeG5YaTJ1QzlwMFBhaWNBLTVNSWVGSDR5b1RpUFhoV08wWEpvekdiNl9ONXIzeWFHLXlOU1drMkxrUDBiMUN2MmVwUndMcUpyRm56MGZZN21nYWVZeDFNWmw0SE04amtTZmYzZElacjFhN3ltbW1RX0liclluOWVrdVZtblpTZ0NTV28xVDZJOTdoNmtRRzFrR0ZLbFBENWlHVg?oc=5","date":"2022-09-02","type":"regulatory","source":"BioWorld News","summary":"Boehringer grabs first FDA approval in rare form of psoriasis - BioWorld News","headline":"Boehringer grabs first FDA approval in rare form of psoriasis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPejhCQlcwcEc3Y1FXNG15U1ZBaWZUdWdkUWlGUDQ4ZjFYSFg5TTBTVG1xaS1UWjA1Y3VSbTBCTDJQbDJfQTBPaDZ1T0dlTHN3bFZtcXc5Q1owdEd4MGdTb2VzZ0s3cWlBYlR4dlVsTGZGYl9KR0t1WmhmeTVrQWx5UmZzeWMtLUFHOUJVdThkZF9rakpwMWNGMHlvSkl5MEZQTVV5UlF6WUVFdUVGX3NJdEE5d3Nwdw?oc=5","date":"2014-02-19","type":"pipeline","source":"Technology Networks","summary":"IMAPAC to Bring Together Over 150 Leading Industry Players - Technology Networks","headline":"IMAPAC to Bring Together Over 150 Leading Industry Players","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}